NL-OMON55365招募中不适用
Beating EATL - towards rationally targeted therapy for enteropathy-associated T-cell lymphoma - Beating EAT
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- * 18 years old
- •- Indication for a biopsy for the diagnosis or monitoring of:
- •non-CD / non-inflamed, CD / non-inflamed, active CD, pre-EATL, EATL
- •- Given informed consent
排除标准
- •- No informed consent
- •- Insufficient knowledge of Dutch language and/or inability to understand the
- •information provided.
研究者
相似试验
进行中（未招募）
1 期
TEAM-Trial: Overcoming the resistance to chemotherapy with the study drug Bortezomib in patients with akute myeloid leukemia : A multi-centre phase II Approach and evaluation with comparable patientsPatients with confirmed diagnosis of Acute Myeloid Leukemia (AML)according to WHO-2016 classification (except acute promyelocytic leukemia) either de novo AML, AML after preceding myelodysplastic or myeloproliferative syndrome (MDS/MPD), and therapy related AML (t-AML) after previous cytotoxic therapy or radiation are eligible either refractory to first line chemotherapy or in first relapse, also after stem cell transplantation.EUCTR2017-005158-12-DERuprecht-Karls-University Heidelberg Medical Faculty, University Hospital50
招募中
不适用
Single-Agent Molecularly Targeted Therapy for Adults with Recurrent Glioblastoma Multiforme: A Meta-AnalysisJPRN-UMIN000005516Kurume University School of Medicine1,000
招募中
不适用
Combination therapy for children with malignant pontine gliomas.NL-OMON28201VU University Medical Center16
尚未招募
不适用
Turner And Klinefelter Treatment Target studyKlinefelter syndrome (KS)monosomy XTurner syndroom (TS)XXY syndrome100836241001470110018515NL-OMON45826Erasmus MC, Universitair Medisch Centrum Rotterdam350
尚未招募
Unknown
et’s get moving – Role of Therapeutic Alliance and Instructor Behavior during the Treatment of Mental IllnessesIncluded are people who are undergoing day-care or full inpatient open treatment with different mental illnessesDRKS00033297Klinikum Wahrendorff GmbH150